Compare MCO & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCO | COR |
|---|---|---|
| Founded | 1900 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.7B | 68.5B |
| IPO Year | 1998 | 2001 |
| Metric | MCO | COR |
|---|---|---|
| Price | $451.35 | $275.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 14 |
| Target Price | ★ $543.75 | $390.62 |
| AVG Volume (30 Days) | 904.4K | ★ 1.8M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.90% | 0.77% |
| EPS Growth | ★ 21.40 | 5.71 |
| EPS | 3.73 | ★ 11.27 |
| Revenue | $4,204,100,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $8.25 | $8.89 |
| Revenue Next Year | $7.82 | $6.75 |
| P/E Ratio | $120.24 | ★ $23.90 |
| Revenue Growth | N/A | ★ 9.31 |
| 52 Week Low | $402.28 | $244.82 |
| 52 Week High | $546.88 | $377.54 |
| Indicator | MCO | COR |
|---|---|---|
| Relative Strength Index (RSI) | 51.25 | 49.40 |
| Support Level | $423.74 | $244.82 |
| Resistance Level | $497.82 | $277.39 |
| Average True Range (ATR) | 11.65 | 5.60 |
| MACD | 0.54 | 2.84 |
| Stochastic Oscillator | 62.21 | 89.09 |
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed-income securities. The ratings segment, Moody's Investors Service, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's profit and often (depending on bond issuance levels) a majority of the firm's revenue. The other segment, Moody's Analytics, consists of decision solutions, research and insights, and data and information.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.